Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 194.08% |
| Q3 2025 | 9.70% |
| Q2 2025 | 28.50% |
| Q1 2025 | -5658.97% |
| Q4 2024 | 97.33% |
| Q3 2024 | 10.86% |
| Q2 2024 | 6.87% |
| Q1 2024 | -124.94% |
| Q4 2023 | 631.82% |
| Q3 2023 | -1.61% |
| Q2 2023 | 41.83% |
| Q1 2023 | -21.68% |
| Q4 2022 | 2.87% |
| Q3 2022 | -10.83% |
| Q2 2022 | 34.97% |
| Q1 2022 | -42.04% |
| Q4 2021 | -2.54% |
| Q3 2021 | 13.42% |
| Q2 2021 | 34.60% |
| Q1 2021 | -31.96% |
| Q4 2020 | -337.36% |
| Q3 2020 | 146.05% |
| Q2 2020 | 8.34% |
| Q1 2020 | -22.85% |
| Q4 2019 | -10.40% |
| Q3 2019 | 11.47% |
| Q2 2019 | 12.26% |
| Q1 2019 | -43.12% |
| Q4 2018 | -0.26% |
| Q3 2018 | -3.98% |
| Q2 2018 | -3.52% |
| Q1 2018 | -58.66% |
| Q4 2017 | 10.84% |
| Q3 2017 | 11.33% |
| Q2 2017 | -135.36% |
| Q1 2017 | 416.55% |
| Q4 2016 | -40.37% |
| Q3 2016 | -16.20% |
| Q2 2016 | 26.52% |
| Q1 2016 | -68.84% |